Free Trial

Houlihan Lokey (HLI) Financials

Houlihan Lokey logo
$138.57 -0.86 (-0.62%)
Closing price 03:58 PM Eastern
Extended Trading
$138.44 -0.13 (-0.09%)
As of 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Houlihan Lokey

Annual Income Statements for Houlihan Lokey

This table shows Houlihan Lokey's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
70 101 180 143 184 313 438 254 280 400 426
Consolidated Net Income / (Loss)
70 108 172 159 184 313 438 254 280 400 424
Net Income / (Loss) Continuing Operations
70 108 172 159 184 313 438 254 280 400 424
Total Pre-Tax Income
126 178 218 224 236 409 604 324 391 531 562
Total Operating Income
126 182 214 219 230 408 613 342 373 503 527
Total Gross Profit
232 290 327 392 422 554 861 697 737 920 1,008
Total Revenue
694 872 963 1,084 1,159 1,525 2,270 1,809 1,914 2,389 2,618
Operating Revenue
694 872 963 1,084 1,159 1,525 2,270 1,809 1,914 2,389 2,618
Total Cost of Revenue
462 582 637 692 738 971 1,409 1,113 1,177 1,469 1,610
Operating Cost of Revenue
462 582 637 692 738 971 1,409 1,113 1,177 1,469 1,610
Total Operating Expenses
106 108 112 173 192 146 248 355 364 418 481
Selling, General & Admin Expense
51 50 49 77 88 85 130 155 168 180 194
Depreciation Expense
7.50 8.85 7.91 14 17 15 49 58 29 41 43
Other Operating Expenses / (Income)
47 49 55 82 87 46 70 107 141 143 152
Restructuring Charge
- - - - - - - 35 36 55 74
Other Special Charges / (Income)
- - - - - - - - -10 - 18
Total Other Income / (Expense), net
-0.77 -3.51 3.42 5.22 6.05 1.07 -8.93 -18 17 29 35
Other Income / (Expense), net
-0.77 -3.51 3.42 5.22 6.05 1.07 -8.93 -18 17 29 35
Income Tax Expense
56 70 46 65 52 96 166 70 110 132 138
Net Income / (Loss) Attributable to Noncontrolling Interest
0.03 - - - 0.00 0.00 0.57 - 0.00 0.00 -1.52
Basic Earnings per Share
$1.18 $1.77 $2.76 $2.56 $2.96 $4.75 $6.74 $4.01 $4.36 $6.08 $6.40
Weighted Average Basic Shares Outstanding
59.04M 61.10M 62.49M 62.21M 62.15M 65.79M 64.97M 63.36M 64.34M 65.72M 66.55M
Diluted Earnings per Share
$1.10 $1.63 $2.60 $2.42 $2.80 $4.55 $6.41 $3.76 $4.11 $5.82 $6.22
Weighted Average Diluted Shares Outstanding
63.48M 66.58M 66.32M 65.85M 65.73M 68.67M 68.26M 67.59M 68.16M 68.66M 68.43M
Weighted Average Basic & Diluted Shares Outstanding
59.10M 61.20M 62.40M 62.20M 65.32M 68.20M 66.54M 68.06M 68.58M 69.79M 69.06M

Quarterly Income Statements for Houlihan Lokey

This table shows Houlihan Lokey's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
67 71 81 89 94 95 122 98 112 117 100
Consolidated Net Income / (Loss)
67 71 81 89 94 95 122 98 112 117 98
Net Income / (Loss) Continuing Operations
67 71 81 89 94 95 122 98 112 117 98
Total Pre-Tax Income
94 103 118 100 136 145 150 98 160 170 135
Total Operating Income
90 97 103 95 131 136 139 90 151 161 125
Total Gross Profit
180 197 208 198 221 244 271 233 254 276 245
Total Revenue
467 511 520 514 575 634 666 605 659 717 636
Operating Revenue
467 511 520 514 575 634 666 605 659 717 636
Total Cost of Revenue
287 314 312 316 354 390 396 372 406 441 391
Operating Cost of Revenue
287 314 312 316 354 390 396 372 406 441 391
Total Operating Expenses
90 100 105 102 91 108 132 143 103 115 120
Selling, General & Admin Expense
40 48 42 41 47 46 45 51 42 51 51
Depreciation Expense
7.09 6.66 8.26 8.86 7.44 9.56 15 16 10 8.30 8.04
Other Operating Expenses / (Income)
33 36 38 38 29 40 36 56 33 38 25
Restructuring Charge
9.34 9.69 - 14 7.04 13 - 21 18 18 18
Total Other Income / (Expense), net
3.30 6.04 15 5.13 5.42 9.02 11 8.25 8.71 8.92 9.37
Other Income / (Expense), net
3.30 6.04 15 5.13 5.42 9.02 11 8.25 8.71 8.92 9.37
Income Tax Expense
27 32 37 11 43 50 28 0.52 48 53 36
Basic Earnings per Share
$1.04 $1.10 $1.26 $1.37 $1.42 $1.45 $1.84 $1.47 $1.67 $1.75 $1.51
Weighted Average Basic Shares Outstanding
64.55M 64.41M 64.34M 65.03M 65.82M 65.83M 65.72M 66.24M 66.96M 66.63M 66.55M
Diluted Earnings per Share
$0.99 $1.04 $1.18 $1.30 $1.37 $1.39 $1.76 $1.42 $1.63 $1.70 $1.47
Weighted Average Diluted Shares Outstanding
67.87M 67.89M 68.16M 68.50M 68.42M 68.76M 68.66M 68.89M 68.59M 68.43M 68.43M
Weighted Average Basic & Diluted Shares Outstanding
69.11M - 68.58M 69.53M 69.50M 70.14M 69.79M 70.31M 70.07M 69.79M 69.06M

Annual Cash Flow Statements for Houlihan Lokey

This table details how cash moves in and out of Houlihan Lokey's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
Net Change in Cash & Equivalents
78 327 -192 -14 95 466 -13 -119 7.04 254 218
Net Cash From Operating Activities
12 252 251 224 288 580 737 136 328 849 704
Net Cash From Continuing Operating Activities
12 252 251 224 288 580 737 136 328 849 704
Net Income / (Loss) Continuing Operations
70 108 172 159 184 313 438 254 280 400 424
Consolidated Net Income / (Loss)
70 108 172 159 184 313 438 254 280 400 424
Depreciation Expense
7.50 8.85 7.91 14 17 15 49 58 29 41 43
Non-Cash Adjustments To Reconcile Net Income
38 43 61 58 94 92 131 194 206 214 247
Changes in Operating Assets and Liabilities, net
-103 91 9.49 -7.15 -7.21 159 118 -370 -186 194 -9.29
Net Cash From Investing Activities
180 -1.65 -219 6.46 -33 -100 -274 -3.00 -70 -265 2.18
Net Cash From Continuing Investing Activities
180 -1.65 -219 6.46 -33 -100 -274 -3.00 -70 -265 2.18
Purchase of Property, Plant & Equipment
-9.39 -14 -7.72 -6.73 -21 -14 -8.68 -51 -67 -40 -22
Acquisitions
-37 -3.73 -2.70 -71 -2.20 -12 -361 -20 -3.86 -69 -2.54
Purchase of Investments
0.00 0.00 -209 -147 -351 -392 -102 -19 -11 -250 -263
Sale and/or Maturity of Investments
226 16 1.16 232 340 318 197 87 11 94 290
Net Cash From Financing Activities
-114 80 -225 -236 -152 -27 -459 -240 -251 -329 -493
Net Cash From Continuing Financing Activities
-114 80 -225 -236 -152 -27 -459 -240 -251 -329 -493
Repayment of Debt
0.00 -95 -21 0.19 0.37 -3.27 0.48 0.57 0.59 0.71 0.00
Repurchase of Common Equity
0.00 -0.96 -18 -70 -30 -102 -305 -49 -25 -53 -175
Payment of Dividends
-114 -55 -52 -67 -81 -92 -115 -140 -148 -165 -174
Other Financing Activities, net
0.05 -27 -228 -100 -42 -18 -40 -52 -78 -112 -143
Other Net Changes in Cash
- - 0.79 -8.70 -7.76 - - - - -0.76 4.93
Cash Income Taxes Paid
75 57 48 81 74 44 242 157 105 93 187

Quarterly Cash Flow Statements for Houlihan Lokey

This table details how cash moves in and out of Houlihan Lokey's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
38 62 166 -272 243 108 175 -177 130 133 133
Net Cash From Operating Activities
136 101 225 -65 289 266 358 -132 325 218 293
Net Cash From Continuing Operating Activities
136 101 225 -65 289 266 358 -132 325 218 293
Net Income / (Loss) Continuing Operations
67 71 81 89 94 95 122 98 112 117 98
Consolidated Net Income / (Loss)
67 71 81 89 94 95 122 98 112 117 98
Depreciation Expense
7.09 6.66 8.26 8.86 7.44 9.56 15 16 10 8.30 8.04
Non-Cash Adjustments To Reconcile Net Income
54 58 45 45 53 61 54 52 58 78 59
Changes in Operating Assets and Liabilities, net
8.00 -35 91 -207 135 99 167 -297 145 15 128
Net Cash From Investing Activities
-21 -23 -15 -40 -31 -87 -106 110 -114 56 -50
Net Cash From Continuing Investing Activities
-21 -23 -15 -40 -31 -87 -106 110 -114 56 -50
Purchase of Property, Plant & Equipment
-23 -16 -12 -11 -10 -3.85 -14 -13 -2.24 -0.64 -6.25
Acquisitions
- -3.85 -0.00 -32 0.04 -37 -0.48 -0.73 - - -1.81
Purchase of Investments
- -3.39 -7.86 -1.49 -22 -91 -136 -153 -130 103 -83
Sale and/or Maturity of Investments
2.66 0.07 5.40 4.02 1.59 44 44 277 18 -46 42
Net Cash From Financing Activities
-68 -36 -36 -161 -39 -37 -91 -197 -72 -131 -93
Net Cash From Continuing Financing Activities
-68 -36 -36 -161 -39 -37 -91 -197 -72 -131 -93
Repurchase of Common Equity
-25 - - -0.24 - -0.09 -52 -7.81 -30 -88 -50
Payment of Dividends
-35 -36 -36 -51 -38 -37 -39 -52 -42 -41 -39
Other Financing Activities, net
-7.31 -0.10 -0.59 -111 -0.72 -0.25 -0.38 -137 -0.64 -2.16 -3.63
Cash Income Taxes Paid
31 37 20 17 20 22 34 11 44 86 46

Annual Balance Sheets for Houlihan Lokey

This table presents Houlihan Lokey's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
Total Assets
1,071 1,386 1,419 1,426 1,677 2,426 2,887 2,969 3,171 3,820 4,309
Total Current Assets
259 564 641 491 601 1,164 1,087 952 992 1,424 1,588
Cash & Equivalents
166 300 207 286 380 847 834 714 721 971 1,189
Short-Term Investments
- 0.00 209 125 135 209 109 37 38 196 170
Accounts Receivable
58 61 123 71 81 108 144 182 200 257 228
Plant, Property, & Equipment, net
22 30 32 31 42 46 52 88 137 149 143
Total Noncurrent Assets
790 791 745 904 1,033 1,215 1,747 1,929 2,042 2,246 2,578
Goodwill
717 715 723 795 813 671 1,070 1,088 1,127 1,285 1,396
Intangible Assets
- - - - - 195 247 203 197 213 204
Other Noncurrent Operating Assets
73 76 22 107 214 321 334 533 627 749 978
Total Liabilities & Shareholders' Equity
1,071 1,386 1,419 1,426 1,677 2,426 2,887 2,969 3,171 3,820 4,309
Total Liabilities
417 655 566 535 693 1,043 1,443 1,356 1,334 1,645 1,856
Total Current Liabilities
339 402 429 468 474 716 1,080 879 840 1,074 1,213
Accounts Payable
34 42 41 55 54 67 126 113 114 137 136
Other Current Liabilities
299 351 378 405 420 648 954 766 726 937 1,077
Total Noncurrent Liabilities
78 253 137 67 218 327 363 476 494 571 643
Other Noncurrent Operating Liabilities
26 210 106 52 214 326 362 476 486 571 643
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
2.40 3.84 - - - - - - - 0.00 111
Total Equity & Noncontrolling Interests
651 727 853 891 984 1,384 1,444 1,613 1,837 2,175 2,342
Total Preferred & Common Equity
651 727 853 922 984 1,384 1,444 1,613 1,837 2,175 2,342
Total Common Equity
651 727 853 922 984 1,384 1,444 1,613 1,837 2,175 2,342
Common Stock
637 855 753 645 650 804 565 643 740 843 746
Retained Earnings
29 87 207 276 377 600 922 1,033 1,163 1,395 1,645
Accumulated Other Comprehensive Income / (Loss)
-15 -22 -14 0.00 -43 -20 -43 -63 -67 -63 -49

Quarterly Balance Sheets for Houlihan Lokey

This table presents Houlihan Lokey's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2022 12/31/2022 6/30/2023 9/30/2023 12/31/2023 6/30/2024 9/30/2024 12/31/2024 6/30/2025 9/30/2025 12/31/2025
Total Assets
2,510 2,672 2,707 2,782 2,959 2,943 3,213 3,476 3,518 3,793 3,937
Total Current Assets
675 734 644 700 777 727 991 1,071 1,092 1,359 1,395
Cash & Equivalents
504 549 456 494 556 450 691 799 794 924 1,056
Short-Term Investments
36 37 34 31 35 36 57 104 73 185 128
Accounts Receivable
135 138 138 152 153 193 219 167 218 251 211
Plant, Property, & Equipment, net
62 76 101 119 131 143 149 140 151 145 141
Total Noncurrent Assets
1,773 1,862 1,962 1,962 2,051 2,073 2,073 2,265 2,275 2,289 2,400
Goodwill
1,051 1,061 1,091 1,086 1,129 1,175 1,178 1,280 1,295 1,292 1,293
Intangible Assets
215 205 200 197 200 199 197 222 204 201 200
Other Noncurrent Operating Assets
395 483 562 572 619 618 612 679 680 796 908
Total Liabilities & Shareholders' Equity
2,510 2,672 2,707 2,782 2,959 2,943 3,213 3,476 3,518 3,793 3,937
Total Liabilities
1,064 1,131 1,092 1,135 1,190 1,113 1,256 1,395 1,340 1,546 1,643
Total Current Liabilities
784 759 565 648 675 601 746 842 746 932 989
Accounts Payable
98 120 91 95 100 110 105 123 106 109 108
Other Current Liabilities
686 639 473 553 575 491 641 719 640 823 881
Total Noncurrent Liabilities
280 372 527 488 514 512 510 553 594 615 654
Other Noncurrent Operating Liabilities
279 331 527 450 470 468 464 505 533 615 654
Commitments & Contingencies
- - - - - 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,447 1,541 1,615 1,646 1,769 1,829 1,957 2,081 2,178 2,247 2,294
Total Preferred & Common Equity
1,447 1,541 1,615 1,646 1,769 1,829 1,957 2,081 2,178 2,247 2,294
Total Common Equity
1,447 1,541 1,615 1,646 1,769 1,829 1,957 2,081 2,178 2,247 2,294
Common Stock
560 602 616 638 702 692 735 852 744 760 735
Retained Earnings
981 1,008 1,059 1,087 1,121 1,207 1,260 1,315 1,449 1,516 1,589
Accumulated Other Comprehensive Income / (Loss)
-94 -70 -60 -80 -54 -70 -38 -86 -15 -29 -29

Annual Metrics And Ratios for Houlihan Lokey

This table displays calculated financial ratios and metrics derived from Houlihan Lokey's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 69,786,159.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 69,786,159.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 6.10
Growth Metrics
- - - - - - - - - - -
Revenue Growth
1.89% 25.70% 10.47% 12.56% 6.91% 31.58% 48.81% -20.29% 5.80% 24.81% 9.55%
EBITDA Growth
-3.28% 40.72% 20.50% 5.78% 5.92% 67.81% 53.72% -41.42% 9.64% 36.64% 5.64%
EBIT Growth
-4.92% 42.07% 22.05% 2.98% 5.05% 73.66% 47.58% -46.35% 20.54% 36.05% 5.82%
NOPAT Growth
-9.81% 57.38% 53.50% -8.36% 15.24% 74.20% 42.59% -39.72% -2.87% 44.87% 5.16%
Net Income Growth
-12.72% 55.29% 59.02% -7.65% 15.52% 70.18% 40.14% -42.00% 10.26% 42.60% 6.12%
EPS Growth
-17.29% 48.18% 59.51% -6.92% 15.70% 62.50% 40.88% -41.34% 9.31% 41.61% 6.87%
Operating Cash Flow Growth
-94.04% 2,050.16% -0.54% -10.52% 28.27% 101.56% 27.04% -81.50% 141.03% 158.36% -17.03%
Free Cash Flow Firm Growth
145.23% 24.07% -81.45% -68.91% 827.38% 134.37% -40.14% -133.79% 148.61% 907.40% -30.02%
Invested Capital Growth
-30.68% -50.26% 40.92% 38.19% -3.09% -30.33% 52.50% 71.88% 25.05% -6.80% 8.43%
Revenue Q/Q Growth
0.00% 9.20% -1.27% 4.49% 0.99% 14.92% -1.28% -1.44% 0.00% 6.51% -1.16%
EBITDA Q/Q Growth
0.00% 8.87% 1.84% 1.50% 4.02% 19.02% -4.83% -5.91% 0.00% 7.38% -3.68%
EBIT Q/Q Growth
0.00% 9.67% 1.99% 0.75% 3.71% 20.24% -7.52% -3.11% 0.00% 6.45% -2.72%
NOPAT Q/Q Growth
0.00% 11.50% 1.53% 4.39% 7.98% 15.81% -6.08% -1.29% 0.00% 12.84% -5.30%
Net Income Q/Q Growth
0.00% 11.64% 2.39% 4.77% 8.03% 14.81% -7.24% -2.12% 0.00% 11.38% -5.27%
EPS Q/Q Growth
0.00% 11.64% 2.36% 4.76% 8.11% 13.75% -6.97% -0.27% 0.00% 11.07% -4.45%
Operating Cash Flow Q/Q Growth
-68.38% 26.11% 4.04% 11.03% 18.40% 19.78% -22.04% 464.31% 0.00% 18.60% -8.49%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% -53.15% -78.33% 35.02% 24.49% -48.44% 63.43% 0.00% 153.52% -35.72%
Invested Capital Q/Q Growth
0.00% -48.39% -30.61% -13.06% -18.94% -32.35% 16.21% -9.77% 0.00% -14.67% -1.49%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
33.46% 33.24% 33.92% 36.18% 36.37% 36.33% 37.94% 36.56% 36.61% 38.50% 38.50%
EBITDA Margin
19.19% 21.48% 23.43% 22.02% 21.82% 27.82% 28.74% 21.12% 21.89% 23.96% 23.11%
Operating Margin
18.22% 20.87% 22.26% 20.20% 19.80% 26.76% 27.00% 18.89% 18.95% 20.99% 20.13%
EBIT Margin
18.11% 20.47% 22.61% 20.69% 20.33% 26.83% 26.61% 17.91% 20.40% 22.24% 21.48%
Profit (Net Income) Margin
10.06% 12.42% 17.88% 14.67% 15.85% 20.50% 19.31% 14.05% 14.64% 16.73% 16.21%
Tax Burden Percent
55.53% 60.70% 79.09% 70.93% 78.00% 76.43% 72.58% 78.46% 71.77% 75.23% 75.44%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
44.47% 39.30% 20.91% 29.07% 22.00% 23.57% 27.42% 21.54% 28.23% 24.77% 24.56%
Return on Invested Capital (ROIC)
11.44% 29.38% 56.34% 37.06% 37.38% 77.98% 107.24% 39.37% 26.88% 36.27% 37.84%
ROIC Less NNEP Spread (ROIC-NNEP)
11.78% 30.05% 55.79% 36.24% 36.35% 77.88% 107.89% 41.01% 24.25% 33.95% 35.73%
Return on Net Nonoperating Assets (RNNOA)
-2.01% -13.72% -34.58% -18.81% -17.78% -51.56% -76.23% -22.74% -10.63% -16.34% -19.51%
Return on Equity (ROE)
9.43% 15.66% 21.76% 18.24% 19.60% 26.42% 31.01% 16.63% 16.25% 19.93% 18.33%
Cash Return on Invested Capital (CROIC)
47.68% 96.50% 22.37% 4.99% 40.52% 113.73% 65.65% -13.51% 4.62% 43.31% 29.75%
Operating Return on Assets (OROA)
10.92% 14.53% 15.53% 15.77% 15.19% 19.95% 22.73% 11.07% 12.72% 15.20% 13.83%
Return on Assets (ROA)
6.06% 8.82% 12.29% 11.19% 11.85% 15.25% 16.50% 8.68% 9.13% 11.44% 10.44%
Return on Common Equity (ROCE)
9.40% 15.59% 21.71% 18.56% 19.91% 26.42% 31.01% 16.63% 16.25% 19.93% 17.89%
Return on Equity Simple (ROE_SIMPLE)
10.71% 14.91% 20.20% 17.26% 18.67% 22.61% 30.36% 15.76% 15.26% 18.38% 0.00%
Net Operating Profit after Tax (NOPAT)
70 110 170 155 179 312 445 268 260 377 398
NOPAT Margin
10.12% 12.67% 17.60% 14.33% 15.45% 20.45% 19.60% 14.82% 13.60% 15.79% 15.19%
Net Nonoperating Expense Percent (NNEP)
-0.34% -0.67% 0.55% 0.82% 1.03% 0.10% -0.65% -1.64% 2.63% 2.32% 2.11%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - 17.35% 16.97%
Cost of Revenue to Revenue
66.54% 66.76% 66.08% 63.82% 63.63% 63.67% 62.06% 63.44% 63.39% 61.50% 61.50%
SG&A Expenses to Revenue
7.33% 5.76% 5.13% 7.12% 7.60% 5.58% 5.71% 8.55% 8.78% 7.51% 7.42%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
15.24% 12.37% 11.66% 15.97% 16.56% 9.58% 10.95% 17.68% 17.65% 17.51% 18.37%
Earnings before Interest and Taxes (EBIT)
126 178 218 224 236 409 604 324 391 531 562
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
133 187 226 239 253 424 652 382 419 573 605
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.07 2.70 3.00 2.90 3.18 3.10 3.90 3.63 4.80 5.21 4.28
Price to Tangible Book Value (P/TBV)
0.00 173.88 19.75 21.04 18.23 8.28 44.72 18.17 17.24 16.72 13.50
Price to Revenue (P/Rev)
1.95 2.25 2.65 2.46 2.70 2.81 2.48 3.24 4.61 4.74 3.83
Price to Earnings (P/E)
19.38 19.40 14.19 18.72 17.01 13.70 12.86 23.03 31.47 28.34 23.54
Dividend Yield
1.45% 2.42% 2.06% 2.64% 2.60% 2.09% 2.06% 2.49% 1.72% 1.41% 1.67%
Earnings Yield
5.16% 5.15% 7.05% 5.34% 5.88% 7.30% 7.77% 4.34% 3.18% 3.53% 4.25%
Enterprise Value to Invested Capital (EV/IC)
2.39 5.94 5.84 4.66 5.54 9.83 9.36 5.92 7.49 10.12 8.03
Enterprise Value to Revenue (EV/Rev)
1.73 1.70 2.14 2.09 2.25 2.12 2.07 2.82 4.21 4.25 3.35
Enterprise Value to EBITDA (EV/EBITDA)
9.03 7.92 9.11 9.50 10.33 7.61 7.19 13.35 19.24 17.74 14.50
Enterprise Value to EBIT (EV/EBIT)
9.57 8.31 9.44 10.11 11.09 7.89 7.76 15.75 20.64 19.12 15.60
Enterprise Value to NOPAT (EV/NOPAT)
17.13 13.43 12.13 14.59 14.59 10.35 10.54 19.03 30.96 26.92 22.07
Enterprise Value to Operating Cash Flow (EV/OCF)
102.59 5.89 8.21 10.11 9.09 5.57 6.37 37.44 24.55 11.97 12.46
Enterprise Value to Free Cash Flow (EV/FCFF)
4.11 4.09 30.55 108.35 13.46 7.10 17.22 0.00 180.28 22.55 28.06
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.02 0.02 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.02 0.02 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.17 -0.46 -0.62 -0.52 -0.49 -0.66 -0.71 -0.55 -0.44 -0.48 -0.55
Leverage Ratio
1.56 1.78 1.77 1.63 1.65 1.73 1.88 1.92 1.78 1.74 1.76
Compound Leverage Factor
1.56 1.78 1.77 1.63 1.65 1.73 1.88 1.92 1.78 1.74 1.76
Debt to Total Capital
2.23% 1.63% 1.02% 0.74% 0.33% 0.06% 0.04% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
2.23% 1.63% 1.02% 0.74% 0.33% 0.06% 0.04% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.36% 0.52% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 4.51%
Common Equity to Total Capital
97.45% 97.86% 98.98% 102.64% 99.67% 99.94% 99.96% 100.00% 100.00% 100.00% 95.49%
Debt to EBITDA
0.11 0.06 0.04 0.03 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
-1.14 -2.57 -2.22 -1.70 -2.03 -2.49 -1.44 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.11 0.06 0.04 0.03 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.21 0.11 0.05 0.04 0.02 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
-2.16 -4.35 -2.95 -2.60 -2.86 -3.38 -2.12 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.21 0.11 0.05 0.04 0.02 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
2.93 3.08 4.28 4.57 4.27 4.22 4.27 4.08 5.55 5.84 4.92
Noncontrolling Interest Sharing Ratio
0.36% 0.43% 0.24% -1.74% -1.62% 0.00% 0.00% 0.00% 0.00% 0.00% 2.39%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.76 1.40 1.50 1.05 1.27 1.63 1.01 1.08 1.18 1.33 1.31
Quick Ratio
0.66 0.90 1.26 1.03 1.26 1.63 1.01 1.06 1.14 1.33 1.31
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
292 363 67 21 194 455 272 -92 45 451 313
Operating Cash Flow to CapEx
124.89% 1,747.35% 3,247.14% 3,334.43% 1,388.23% 4,098.37% 8,486.22% 268.62% 492.22% 2,137.61% 3,155.84%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.60 0.71 0.69 0.76 0.75 0.74 0.85 0.62 0.62 0.68 0.64
Accounts Receivable Turnover
12.00 14.68 10.48 11.18 15.28 16.12 17.98 11.10 10.03 10.46 10.78
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
36.33 33.47 30.80 34.33 31.59 34.38 46.07 25.75 17.01 16.71 17.91
Accounts Payable Turnover
12.90 15.31 15.45 14.45 13.55 16.01 14.55 9.58 10.66 11.69 11.79
Days Sales Outstanding (DSO)
30.41 24.86 34.83 32.64 23.89 22.65 20.30 32.89 36.38 34.90 33.86
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
28.30 23.84 23.63 25.27 26.95 22.80 25.09 38.10 34.23 31.22 30.97
Cash Conversion Cycle (CCC)
2.10 1.03 11.20 7.37 -3.06 -0.15 -4.79 -5.21 2.16 3.68 2.89
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
502 250 352 487 472 329 501 861 1,077 1,004 1,093
Invested Capital Turnover
1.13 2.32 3.20 2.59 2.42 3.81 5.47 2.66 1.98 2.30 2.49
Increase / (Decrease) in Invested Capital
-222 -252 102 134 -15 -143 172 360 216 -73 85
Enterprise Value (EV)
1,202 1,484 2,057 2,268 2,614 3,230 4,689 5,102 8,062 10,157 8,774
Market Capitalization
1,351 1,960 2,557 2,673 3,126 4,285 5,631 5,854 8,822 11,328 10,023
Book Value per Share
$9.97 $10.89 $12.94 $14.09 $15.01 $20.07 $21.43 $23.51 $26.58 $31.01 $33.57
Tangible Book Value per Share
($1.01) $0.17 $1.97 $1.94 $2.62 $7.50 $1.87 $4.69 $7.41 $9.66 $10.64
Total Capital
668 743 862 898 988 1,384 1,444 1,613 1,837 2,175 2,453
Total Debt
15 12 8.83 6.61 3.28 0.82 0.54 0.00 0.00 0.00 0.00
Total Long-Term Debt
15 12 8.83 6.61 3.28 0.82 0.54 0.00 0.00 0.00 0.00
Net Debt
-151 -481 -501 -405 -513 -1,055 -943 -752 -760 -1,171 -1,360
Capital Expenditures (CapEx)
9.39 14 7.72 6.73 21 14 8.68 51 67 40 22
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-246 -330 -297 -388 -389 -607 -936 -680 -608 -817 -984
Debt-free Net Working Capital (DFNWC)
-80 163 213 23 127 448 7.45 73 152 355 375
Net Working Capital (NWC)
-80 163 213 23 127 448 7.45 73 152 355 375
Net Nonoperating Expense (NNE)
0.43 2.13 -2.71 -3.70 -4.72 -0.82 6.48 14 -20 -22 -27
Net Nonoperating Obligations (NNO)
-151 -481 -501 -405 -513 -1,055 -943 -752 -760 -1,171 -1,360
Total Depreciation and Amortization (D&A)
7.50 8.85 7.91 14 17 15 49 58 29 41 43
Debt-free, Cash-free Net Working Capital to Revenue
-35.50% -37.86% -30.81% -35.79% -33.56% -39.82% -41.22% -37.56% -31.74% -34.17% -37.60%
Debt-free Net Working Capital to Revenue
-11.55% 18.64% 22.08% 2.15% 10.96% 29.39% 0.33% 4.01% 7.95% 14.84% 14.35%
Net Working Capital to Revenue
-11.55% 18.64% 22.08% 2.15% 10.96% 29.39% 0.33% 4.01% 7.95% 14.84% 14.35%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.18 $1.77 $2.76 $2.56 $2.96 $4.75 $6.74 $4.01 $4.36 $6.08 $6.40
Adjusted Weighted Average Basic Shares Outstanding
59.04M 61.10M 62.49M 62.21M 62.15M 65.79M 64.97M 63.36M 64.34M 65.72M 66.55M
Adjusted Diluted Earnings per Share
$1.10 $1.63 $2.60 $2.42 $2.80 $4.55 $6.41 $3.76 $4.11 $5.82 $6.22
Adjusted Weighted Average Diluted Shares Outstanding
63.48M 66.58M 66.32M 65.85M 65.73M 68.67M 68.26M 67.59M 68.16M 68.66M 68.43M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
66.84M 67.13M 66.88M 66.24M 65.32M 68.20M 66.54M 68.06M 68.58M 69.79M 69.06M
Normalized Net Operating Profit after Tax (NOPAT)
70 110 170 155 179 312 445 268 260 419 467
Normalized NOPAT Margin
10.12% 12.67% 17.60% 14.33% 15.45% 20.45% 19.60% 14.82% 13.60% 17.52% 17.83%
Pre Tax Income Margin
18.11% 20.47% 22.61% 20.69% 20.33% 26.83% 26.61% 17.91% 20.40% 22.24% 21.48%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
163.83% 51.04% 30.23% 42.07% 43.88% 29.42% 26.19% 55.22% 52.96% 41.33% 41.03%
Augmented Payout Ratio
163.83% 51.92% 40.72% 85.79% 60.01% 62.10% 95.73% 74.36% 61.86% 54.47% 82.39%

Quarterly Metrics And Ratios for Houlihan Lokey

This table displays calculated financial ratios and metrics derived from Houlihan Lokey's official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 69,786,159.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 69,786,159.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 1.43
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-4.61% 11.97% 17.02% 23.51% 23.12% 24.12% 28.05% 17.86% 14.70% 13.03% -4.62%
EBITDA Growth
-2.97% 12.77% 45.76% 31.18% 42.59% 41.61% 31.17% 4.88% 18.69% 15.04% -13.95%
EBIT Growth
11.04% 22.68% 46.99% 30.81% 45.44% 41.48% 27.29% -1.83% 17.61% 16.90% -10.48%
NOPAT Growth
0.41% 4.98% 4.77% 44.31% 38.90% 34.13% 60.13% 5.88% 17.67% 23.54% -20.09%
Net Income Growth
10.38% 12.29% 35.90% 44.88% 39.56% 34.60% 50.38% 9.66% 19.49% 22.29% -19.36%
EPS Growth
13.79% 15.56% 22.92% 44.44% 38.38% 33.65% 49.15% 9.23% 18.98% 22.30% -16.48%
Operating Cash Flow Growth
59.59% 10.82% -5.39% 51.70% 112.95% 163.16% 59.06% -104.04% 12.39% -18.01% -18.23%
Free Cash Flow Firm Growth
75.55% 322.08% 50.42% 22.49% 129.33% -206.44% 228.24% 193.94% 188.49% 116.28% -96.45%
Invested Capital Growth
29.85% 0.00% 25.05% 19.46% 2.49% 0.00% -6.80% -2.75% -5.69% -5.66% 8.43%
Revenue Q/Q Growth
12.30% 9.45% 1.82% 0.00% 11.94% 10.34% 5.04% -9.16% 8.94% 8.74% -11.36%
EBITDA Q/Q Growth
21.45% 8.52% 15.63% 0.00% 32.01% 7.77% 7.10% -31.16% 49.38% 4.45% -19.89%
EBIT Q/Q Growth
22.55% 9.62% 15.08% 0.00% 36.26% 6.64% 3.54% -34.74% 63.24% 5.99% -20.71%
NOPAT Q/Q Growth
9.66% 3.04% 5.86% 0.00% 5.54% -0.49% 26.37% -20.92% 18.33% 4.47% -17.17%
Net Income Q/Q Growth
9.19% 5.63% 14.51% 0.00% 5.18% 1.87% 27.93% -20.00% 14.61% 4.26% -15.65%
EPS Q/Q Growth
10.00% 5.05% 13.46% 0.00% 5.38% 1.46% 26.62% -19.32% 14.79% 4.29% -13.53%
Operating Cash Flow Q/Q Growth
201.69% -25.71% 123.31% 0.00% 548.33% -8.20% 34.98% -136.73% 346.94% -33.03% 34.62%
Free Cash Flow Firm Q/Q Growth
-19.46% 595.39% -114.22% 0.00% 145.21% -1,897.63% 117.13% -32.15% 38.07% 1.45% -96.32%
Invested Capital Q/Q Growth
4.74% -100.00% 0.00% 0.00% -10.13% -2.58% -14.67% 30.18% -12.85% -2.55% -1.49%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
38.50% 38.50% 39.99% 35.73% 38.50% 38.50% 40.64% 38.50% 38.50% 38.50% 38.50%
EBITDA Margin
21.55% 21.37% 24.27% 21.17% 24.96% 24.38% 24.86% 18.84% 25.83% 24.82% 22.43%
Operating Margin
19.33% 18.89% 19.73% 18.61% 22.73% 21.45% 20.89% 14.83% 22.95% 22.41% 19.69%
EBIT Margin
20.04% 20.07% 22.68% 19.45% 23.67% 22.87% 22.55% 16.20% 24.27% 23.66% 21.16%
Profit (Net Income) Margin
14.35% 13.85% 15.58% 17.32% 16.27% 15.02% 18.29% 16.11% 16.95% 16.25% 15.47%
Tax Burden Percent
71.64% 69.03% 68.69% 89.05% 68.74% 65.67% 81.14% 99.47% 69.84% 68.70% 73.09%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
28.37% 30.97% 31.31% 10.95% 31.26% 34.33% 18.86% 0.53% 30.16% 31.30% 26.91%
Return on Invested Capital (ROIC)
23.70% 0.00% 26.78% 27.02% 27.77% 53.74% 38.93% 27.63% 35.06% 35.68% 35.85%
ROIC Less NNEP Spread (ROIC-NNEP)
23.28% 0.00% 25.38% 26.23% 27.22% 52.43% 38.00% 26.42% 34.40% 35.09% 35.30%
Return on Net Nonoperating Assets (RNNOA)
-8.18% 0.00% -11.12% -7.43% -9.79% -22.79% -18.29% -8.95% -15.20% -16.75% -19.27%
Return on Equity (ROE)
15.51% 0.00% 15.65% 19.58% 17.98% 30.95% 20.64% 18.68% 19.85% 18.93% 16.57%
Cash Return on Invested Capital (CROIC)
-1.55% 0.00% 4.62% 5.47% 23.66% -143.15% 43.31% 31.69% 39.84% 42.55% 29.75%
Operating Return on Assets (OROA)
13.07% 0.00% 14.14% 13.85% 16.26% 14.76% 15.41% 12.44% 17.78% 16.91% 13.63%
Return on Assets (ROA)
9.36% 0.00% 9.71% 12.33% 11.18% 9.70% 12.51% 12.38% 12.41% 11.61% 9.96%
Return on Common Equity (ROCE)
15.51% 0.00% 15.65% 19.58% 17.98% 30.95% 20.64% 18.68% 19.85% 18.93% 16.18%
Return on Equity Simple (ROE_SIMPLE)
14.19% 0.00% 0.00% 16.83% 17.09% 17.25% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
65 67 71 85 90 89 113 89 106 110 91
NOPAT Margin
13.85% 13.04% 13.55% 16.57% 15.62% 14.09% 16.95% 14.76% 16.03% 15.40% 14.39%
Net Nonoperating Expense Percent (NNEP)
0.42% 0.00% 1.39% 0.79% 0.56% 1.31% 0.93% 1.21% 0.66% 0.59% 0.54%
Return On Investment Capital (ROIC_SIMPLE)
- - 3.84% - - 4.30% 5.19% 4.10% 4.70% 4.81% 3.90%
Cost of Revenue to Revenue
61.50% 61.50% 60.01% 64.27% 61.50% 61.50% 59.36% 61.50% 61.50% 61.50% 61.50%
SG&A Expenses to Revenue
8.55% 9.31% 7.98% 8.04% 8.26% 7.19% 6.78% 8.36% 6.32% 7.14% 8.00%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
19.17% 19.61% 20.26% 17.12% 15.77% 17.05% 19.75% 23.67% 15.55% 16.09% 18.81%
Earnings before Interest and Taxes (EBIT)
94 103 118 100 136 145 150 98 160 170 135
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
101 109 126 109 144 155 166 114 170 178 143
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
4.12 0.00 4.76 5.06 5.61 5.80 5.21 5.77 6.43 5.32 4.28
Price to Tangible Book Value (P/TBV)
16.56 0.00 17.07 20.31 18.86 20.88 16.72 18.50 19.15 15.23 13.50
Price to Revenue (P/Rev)
4.09 4.43 4.56 4.60 5.18 5.38 4.74 5.06 5.63 4.61 3.83
Price to Earnings (P/E)
29.06 31.47 31.16 30.04 32.86 33.63 28.34 30.76 33.85 27.26 23.54
Dividend Yield
2.05% 1.85% 1.74% 1.65% 1.42% 1.30% 1.41% 1.28% 1.14% 1.36% 1.67%
Earnings Yield
3.44% 3.18% 3.21% 3.33% 3.04% 2.97% 3.53% 3.25% 2.95% 3.67% 4.25%
Enterprise Value to Invested Capital (EV/IC)
5.69 0.00 7.41 6.52 8.48 9.49 10.12 8.95 11.71 9.93 8.03
Enterprise Value to Revenue (EV/Rev)
3.76 0.00 4.17 4.36 4.83 4.98 4.25 4.71 5.19 4.16 3.35
Enterprise Value to EBITDA (EV/EBITDA)
18.27 0.00 19.03 19.70 20.99 20.94 17.74 20.22 22.04 17.55 14.50
Enterprise Value to EBIT (EV/EBIT)
20.09 0.00 20.42 21.16 22.42 22.37 19.12 22.07 24.08 19.07 15.60
Enterprise Value to NOPAT (EV/NOPAT)
26.34 0.00 30.62 30.61 32.86 33.39 26.92 30.52 33.43 26.25 22.07
Enterprise Value to Operating Cash Flow (EV/OCF)
20.23 0.00 24.28 22.05 18.58 15.60 11.97 14.96 16.31 14.32 12.46
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 178.33 129.88 36.28 0.00 22.55 27.83 28.52 22.66 28.06
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.35 0.00 -0.44 -0.28 -0.36 -0.43 -0.48 -0.34 -0.44 -0.48 -0.55
Leverage Ratio
1.70 0.00 1.78 1.64 1.66 1.67 1.74 1.61 1.67 1.69 1.76
Compound Leverage Factor
1.70 0.00 1.78 1.64 1.66 1.67 1.74 1.61 1.67 1.69 1.76
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 4.51%
Common Equity to Total Capital
100.00% 0.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 95.49%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
4.96 0.00 5.23 6.41 6.69 6.58 5.51 7.12 7.11 5.96 4.59
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.39%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.15 0.00 1.18 1.21 1.33 1.27 1.33 1.46 1.46 1.41 1.31
Quick Ratio
1.10 0.00 1.14 1.13 1.30 1.27 1.33 1.45 1.46 1.41 1.31
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-206 1,021 -145 -134 60 -1,087 186 126 174 177 6.51
Operating Cash Flow to CapEx
583.59% 647.60% 1,843.33% -593.37% 2,755.55% 6,896.47% 2,474.86% -998.33% 14,523.95% 34,066.04% 4,688.53%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.65 0.00 0.62 0.71 0.69 0.65 0.68 0.77 0.73 0.71 0.64
Accounts Receivable Turnover
12.39 0.00 10.03 12.19 11.40 13.46 10.46 12.08 10.91 14.03 10.78
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
18.50 0.00 17.01 16.46 15.18 16.01 16.71 16.88 17.46 18.81 17.91
Accounts Payable Turnover
11.31 0.00 10.35 12.73 13.14 11.55 11.69 14.15 14.78 14.11 11.79
Days Sales Outstanding (DSO)
29.46 0.00 36.38 29.94 32.01 27.12 34.90 30.21 33.45 26.02 33.86
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
32.26 0.00 35.28 28.68 27.78 31.59 31.22 25.80 24.70 25.86 30.97
Cash Conversion Cycle (CCC)
-2.80 0.00 1.10 1.26 4.23 -4.48 3.68 4.41 8.76 0.16 2.89
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,178 0.00 1,077 1,344 1,207 1,176 1,004 1,307 1,139 1,110 1,093
Invested Capital Turnover
1.71 0.00 1.98 1.63 1.78 3.81 2.30 1.87 2.19 2.32 2.49
Increase / (Decrease) in Invested Capital
271 -954 216 219 29 1,176 -73 -37 -69 -67 85
Enterprise Value (EV)
6,707 0.00 7,975 8,763 10,238 11,165 10,157 11,688 13,328 11,021 8,774
Market Capitalization
7,298 8,148 8,735 9,249 10,988 12,069 11,328 12,559 14,436 12,205 10,023
Book Value per Share
$25.52 $0.00 $26.58 $26.68 $28.15 $29.94 $31.01 $31.20 $31.96 $32.74 $33.57
Tangible Book Value per Share
$6.36 $0.00 $7.41 $6.64 $8.38 $8.32 $9.66 $9.73 $10.72 $11.44 $10.64
Total Capital
1,769 0.00 1,837 1,829 1,957 2,081 2,175 2,178 2,247 2,294 2,453
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-591 0.00 -760 -486 -750 -904 -1,171 -871 -1,108 -1,184 -1,360
Capital Expenditures (CapEx)
23 16 12 11 10 3.85 14 13 2.24 0.64 6.25
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-490 0.00 -608 -360 -505 -676 -817 -525 -680 -778 -984
Debt-free Net Working Capital (DFNWC)
102 0.00 152 126 245 229 355 346 428 406 375
Net Working Capital (NWC)
102 0.00 152 126 245 229 355 346 428 406 375
Net Nonoperating Expense (NNE)
-2.36 -4.17 -11 -3.83 -3.73 -5.92 -8.97 -8.21 -6.08 -6.13 -6.85
Net Nonoperating Obligations (NNO)
-591 0.00 -760 -486 -750 -904 -1,171 -871 -1,108 -1,184 -1,360
Total Depreciation and Amortization (D&A)
7.09 6.66 8.26 8.86 7.44 9.56 15 16 10 8.30 8.04
Debt-free, Cash-free Net Working Capital to Revenue
-27.45% 0.00% -31.74% -17.91% -23.82% -30.12% -34.17% -21.18% -26.52% -29.37% -37.60%
Debt-free Net Working Capital to Revenue
5.69% 0.00% 7.95% 6.24% 11.54% 10.19% 14.84% 13.94% 16.67% 15.34% 14.35%
Net Working Capital to Revenue
5.69% 0.00% 7.95% 6.24% 11.54% 10.19% 14.84% 13.94% 16.67% 15.34% 14.35%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $1.26 $1.37 $1.42 $1.45 $1.84 $1.47 $1.67 $1.75 $1.51
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 64.34M 65.03M 65.82M 65.83M 65.72M 66.24M 66.96M 66.63M 66.55M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $1.18 $1.30 $1.37 $1.39 $1.76 $1.42 $1.63 $1.70 $1.47
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 68.16M 68.50M 68.42M 68.76M 68.66M 68.89M 68.59M 68.43M 68.43M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 68.58M 69.53M 69.50M 70.14M 69.79M 70.31M 70.07M 69.79M 69.06M
Normalized Net Operating Profit after Tax (NOPAT)
71 73 71 85 95 98 113 110 118 122 105
Normalized NOPAT Margin
15.28% 14.35% 13.55% 16.57% 16.46% 15.41% 16.95% 18.13% 17.90% 17.08% 16.44%
Pre Tax Income Margin
20.04% 20.07% 22.68% 19.45% 23.67% 22.87% 22.55% 16.20% 24.27% 23.66% 21.16%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
57.33% 56.10% 52.96% 51.24% 48.07% 45.21% 41.33% 40.76% 39.81% 38.72% 41.03%
Augmented Payout Ratio
67.16% 65.57% 61.86% 59.43% 48.14% 45.30% 54.47% 55.48% 60.86% 78.39% 82.39%

Financials Breakdown Chart

Key Financial Trends

Houlihan Lokey’s latest quarter showed solid profitability and very strong cash generation, but results also highlight a business that is becoming more dependent on expense control, restructuring charges, and balance-sheet management.

For the quarter ended March 31, 2026, revenue fell to $635.6 million from $717.1 million in the prior quarter and from $666.4 million in the year-ago comparable period. Net income also eased to $98.3 million, down from $116.5 million in the prior quarter. Even so, the company remained highly profitable, with diluted EPS of $1.47.

Cash flow remains a standout. In Q4 2026, Houlihan Lokey generated $293.0 million of operating cash flow, well above net income, which suggests strong earnings quality and substantial non-cash adjustments. That said, the company continued to return a lot of capital to shareholders through dividends and buybacks, while also making selective investments and acquisitions.

Looking at the last several years, Houlihan Lokey has generally posted consistent revenue growth, healthy margins, and strong cash conversion. However, operating expenses have also climbed, and restructuring charges have appeared regularly, which can signal a somewhat uneven cost structure in a cyclical advisory environment.

  • Strong operating cash flow: Q4 2026 operating cash flow was $293.0 million, comfortably above net income.
  • Consistent profitability: The company remained solidly profitable across the periods provided, with quarterly net income generally ranging around $60 million to $121 million.
  • Revenue trend is up over time: Revenue rose from roughly $415.8 million in Q1 2024 to $635.6 million in Q4 2026, showing meaningful long-term growth.
  • Healthy balance sheet equity: Total common equity was $2.29 billion in Q3 2026, indicating a substantial equity base.
  • Large cash position: Cash and equivalents were $1.06 billion in Q3 2026, giving the company plenty of liquidity.
  • Cash generation supports capital returns: Houlihan Lokey consistently paid dividends and repurchased shares, which is a sign of financial flexibility.
  • EPS has been relatively steady: Diluted EPS moved within a fairly tight range over the periods shown, suggesting stable underlying earnings power.
  • Asset mix is heavily goodwill- and intangible-driven: A large share of assets sits in goodwill, intangibles, and other noncurrent operating assets, which is common after acquisitions but worth monitoring.
  • Revenue declined sequentially in the latest quarter: Q4 2026 revenue fell from Q3 2026, suggesting some near-term softness.
  • Restructuring charges remain recurring: The company recorded restructuring charges in multiple quarters, which can point to ongoing business realignment or cost pressure.
  • Operating expenses have risen meaningfully: SG&A, other operating expenses, and restructuring costs have increased at times, pressuring operating leverage.
  • Cash declined from Q3 2026 to Q4 2026: Cash and equivalents fell from $1.06 billion to $942.0 million as the company returned capital and invested cash.

Bottom line: Houlihan Lokey still looks like a financially strong, cash-generative advisory firm with a durable profitability profile. The main watch items are the softer recent revenue trend, recurring restructuring costs, and the fact that margins depend heavily on keeping operating expenses under control.

06/03/26 09:12 PM ETAI Generated. May Contain Errors.

Houlihan Lokey Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Houlihan Lokey's fiscal year ends in March. Their fiscal year 2026 ended on March 31, 2026.

Houlihan Lokey's net income appears to be on an upward trend, with a most recent value of $424.17 million in 2026, rising from $69.77 million in 2016. The previous period was $399.71 million in 2025. See Houlihan Lokey's forecast for analyst expectations on what's next for the company.

Houlihan Lokey's total operating income in 2026 was $527.02 million, based on the following breakdown:
  • Total Gross Profit: $1.01 billion
  • Total Operating Expenses: $480.73 million

Over the last 10 years, Houlihan Lokey's total revenue changed from $693.77 million in 2016 to $2.62 billion in 2026, a change of 277.3%.

Houlihan Lokey's total liabilities were at $1.86 billion at the end of 2026, a 12.8% increase from 2025, and a 344.7% increase since 2016.

In the past 10 years, Houlihan Lokey's cash and equivalents has ranged from $166.17 million in 2016 to $1.19 billion in 2026, and is currently $1.19 billion as of their latest financial filing in 2026.

Over the last 10 years, Houlihan Lokey's book value per share changed from 9.97 in 2016 to 33.57 in 2026, a change of 236.6%.



Financial statements for NYSE:HLI last updated on 5/27/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners